The number of suspected adverse events (AEs) reported in the European Union/European Economic Area (EU/EEA) up to the end of October stands at 749,979 out of almost 575 million doses, according to the latest data from the European Medicines Agency (EMA). The figure suggests a rate of 1.3 per cent, although...